Literature DB >> 30379231

Potential effect of Zika virus infection on human male fertility?

Vivian Iida Avelino-Silva1, Conrado Alvarenga2, Carolina Abreu2, Tania Regina Tozetto-Mendoza3, Cynthia Liliane Motta do Canto3, Erika Regina Manuli3, Maria Cassia Mendes-Correa3, Ester Cerdeira Sabino3, Walter Manso Figueiredo4, Aluísio Cotrim Segurado1, Philippe Mayaud5.   

Abstract

BACKGROUND: Zika virus (ZIKV) sexual transmission and prolonged viral shedding in semen have been previously reported, suggesting a strong viral affinity for genital tissues. A transient impact of ZIKV on male fertility was shown in animal and human studies.
METHODS: Adult male patients with confirmed ZIKV infection diagnosed in the city of Araraquara, Brazil during the epidemic season of 2016 were invited one year after the acute infection to respond to a questionnaire of genital symptoms and to provide a semen sample for molecular ZIKV testing and spermogram analysis, as well as a serum sample for hormonal testing.
RESULTS: 101 of 187 tested patients had positive ZIKV RT-PCR in plasma and/or urine samples (54%, 72 women and 29 men). Of 15 adult male participants for whom telephone contact was successful, 14 responded to the questionnaire of genital symptoms and six consented to provide a semen sample at a median of 12 months after the acute infection. We report abnormal spermogram results from patients one year after confirmed ZIKV infection.
CONCLUSIONS: Our findings suggest a possible long-term detrimental effect of ZIKV infection on human male fertility that has to be further explored in well-characterized samples from cohort studies conducted in ZIKV-endemic areas.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30379231      PMCID: PMC6201741          DOI: 10.1590/S1678-9946201860064

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


BACKGROUND

The Zika virus (ZIKV) infection outbreak in the Americas in the last few years was the largest in history, and knowledge on disease transmission routes, clinical spectrum and potential complications is still expanding. ZIKV is transmitted mainly through the bite of Aedes mosquitos , but maternal-to-child transmission , transmission through contaminated blood and sexual intercourse were also reported. Viral shedding in semen may be prolonged with documented shedding lasting up to six months – . The virus has been detected in semen from a vasectomized man and has also been demonstrated in the head of spermatozoa by immunohistochemical fluorescence microscopy , suggesting its affinity for different male genital tissues. Worryingly, two previous studies of ZIKV infection in mice treated with anti-Ifnar1 blocking monoclonal antibody have demonstrated impairment in male fertility, accompanied by testicular atrophy, lower serum testosterone and inhibin B levels, as well as oligospermia , . A recent study in a cohort of 15 ZIKV-infected men showed a transient reduction in sperm counts in the acute phase of infection, suggesting a potential impact of ZIKV on human male fertility . However, ZIKV ability to cause long-term impairment on male fertility is unknown. From a cohort of 101 ZIKV-infected patients from Araraquara, Brazil, we assessed hormonal results from six ZIKV-infected men, of whom five underwent spermogram analysis in samples collected 12 months after the acute infection.

METHODS

Patients with confirmed ZIKV infection diagnosed at a single primary care unit during the epidemic season of 2016 in Araraquara, Sao Paulo State, Brazil, were identified for this study. All participants had a positive test by real-time reverse transcriptase polymerase chain reaction (RT-PCR) in urine and/or plasma samples obtained during the acute phase. Adult male patients were invited to respond to a short retrospective questionnaire of genital symptoms and to provide a semen sample for molecular ZIKV testing and spermogram analysis, as well as a serum sample for hormonal testing (FSH, LH, testosterone and inhibin B). Each participant was instructed to produce and collect the semen sample at home by masturbation and to bring the sample immediately, in room temperature, to the healthcare unit for analysis. The questionnaire of genital symptoms included questions on the presence of pain or burning when urinating, noticeable blood in semen or urine, testicular pain and any genital abnormality at the time of acute ZIKV infection or at the time the questionnaire was applied. For RT-PCR testing, nucleic acid was extracted from a volume of 500 μL of total semen samples using the NucliSENS® easyMag® (bioMérieux, Durham, NC). Samples of total semen and seminal plasma were then reextracted using Qiagen® QIAamp Viral RNA mini kit 250 (QIAGEN, Hilden, Germany) according to manufacturer's recommendation. All RT-PCRs were performed with 10 μL of RNA samples by using the Taqman Fast virus OneStep Kit (Applied Biosystems, Forest City, CA) as previously described and following the manufacturer's protocol. Spermograms were all read fresh at the Araraquara clinic by a single experienced fertility clinic technician who was not blinded to the ZIKV status of the patients. FSH and LH hormonal levels were measured using electrochemiluminometric assays, while testosterone and inhibin B were measured using serum samples chemiluminescence assays. For comparison, spermogram results were compared with normal parameters from the World Health Organization (WHO) and with parameters obtained from a consecutive sample of men without history of ZIKV symptoms and without past history of infertility who collected semen samples in the same region (State) and period. All participants signed informed consent forms upon participation. The study was approved by the Ethics Review Board at University of Sao Paulo Medical School (committee's reference N° 2.554.861).

RESULTS

Between January and September 2016, 238 suspected ZIKV notifications were reported at Araraquara referent healthcare unit. Clinical definition of notified cases included patients presenting with maculopapular rash along with at least two of the following symptoms: fever, conjunctivitis, arthritis or periarticular edema. Of these patients, 187 were tested by RT-PCR and 101 (29 men) had positive ZIKV RT-PCR in plasma and/or urine samples. Adult male patients with confirmed ZIKV infections were invited to respond to a retrospective questionnaire of genital symptoms and to provide a semen sample for RT-PCR testing and spermogram analysis. Of 15 adult male participants for whom telephone contact was successful, 14 responded to the questionnaire of genital symptoms and six consented to provide a semen sample at a median of 12 months after the acute infection (range 11-12 months; Figure 1). All semen samples were delivered < 3 h after production. In the questionnaire of genital symptoms, two participants reported burning sensation when urinating at the time of acute ZIKV infection and one reported visible blood in urine; testicular pain or other abnormalities were not described and all participants were asymptomatic at the time the questionnaire was applied.
Figure 1

Selection of study participants.

ZIKV RT-PCR was negative in semen samples for all six participants. Spermogram analysis was performed for five participants, revealing abnormalities in seminal parameters in four of them, compared to WHO standards and local healthy men values. Although only one participant had sperm concentration below the lower reference limit (LRL) of 15 × 106/mL, two other participants had concentration near the LRL (17 and 26 × 106/mL). Progressive motility analysis was performed for three participants who delivered the semen sample less than 2 h after production; abnormal motility was seen in all three cases (2.5%, 14% and 22% progressive motility, respectively compared to expected LRL of 32%). Table 1 shows results for each ZIKV-infected participant, contrasted with LRL from WHO and with median parameters of 17 local, healthy men without history of ZIKV symptoms or infertility antecedents. Of note, this comparison group was younger than ZIKV-infected patients included in the study. No ZIKV testing was performed in plasma, urine or semen specimens of this comparison group. Hormonal testing revealed no anomalies; values of testosterone (in patient 6) and inhibin B (in patient 1) were low, although still within the reference values.
Table 1

Spermogram and hormonal parameters for ZIKV-infected and asymptomatic individuals in Sao Paulo, Brazil, compared to international (WHO) reference standards.

Patient 1Patient 2Patient 3Patient 4Patient 5Patient 6Asymptomatic individuals* (N=17)Reference values **
Age (years)61704438496633 (30-35)
Months after ZIKV infection1211121212NA
Sperm concentration per ml8.9 × 106 17.0 × 106 60.0 × 106 43.0 × 106 26.0 × 106 NA33 (22-60)>15.0×106
Progressive motility, %2.5NANA2214NA42 (32-54)>32%
Morphology strict criteria (Kruger), %2342332 (2-2)>4%
Hormonal parameters
FSH, IU/L8.13.54.53.13.32.3NT<10.0
LH, IU/LNT3.43.73.36.02.4NT<9.0
Testosterone, ng/dL395334548322346286NT240-816
Inhibin B, pg/mL79138119153114123NT47-308

Men without a history of ZIKV symptoms and without infertility antecedents who collected semen samples in the same region and period. Data for asymptomatic participants is presented as medians and interquartile ranges.

Reference values are WHO LRL (low reference limits) for spermiogram; and Brazilian laboratory own range for hormonal levels. FSH=follicle stimulating hormone; LH=luteinizing hormone; NT=not tested.

Men without a history of ZIKV symptoms and without infertility antecedents who collected semen samples in the same region and period. Data for asymptomatic participants is presented as medians and interquartile ranges. Reference values are WHO LRL (low reference limits) for spermiogram; and Brazilian laboratory own range for hormonal levels. FSH=follicle stimulating hormone; LH=luteinizing hormone; NT=not tested. ZIKV-infected participants with abnormal spermogram results were referred for a free a consultation with a fertility specialist, but results from this evaluation were not available at the time of reporting.

DISCUSSION AND CONCLUSIONS

Despite methodological limitations, restricted number of cases and incomplete semen analysis for two cases, our findings suggest a possible detrimental effect of ZIKV infection on human male fertility detectable at approximately 12 months after the acute ZIKV infection. Since spermatogenesis process in humans takes less than three months, our results indicate a possible persistent impairment in male fertility following symptomatic ZIKV infection. However, the normality of hormonal profiles of these men may be reassuring. This association should be further explored in well-characterized samples from cohort studies conducted in ZIKV-endemic areas including both symptomatic and asymptomatic men. Our results in an extension of a cohort study of 15 ZIKV-infected men followed up in Guadeloupe over six months, who showed a temporary effect of ZIKV on spermatogenesis and hormonal profiles, correlated with persistence of ZIKV shedding in the semen . Since approximately half a million Brazilian men may have been infected with ZIKV during the 2015-16 epidemic , , the long-term fertility sequelae may only appear now. ZIKV should be part of the investigations for men presenting to clinical services with fertility problems.
  13 in total

1.  Long-Lasting Persistence of Zika Virus in Semen.

Authors:  Sophie Matheron; Eric d'Ortenzio; Isabelle Leparc-Goffart; Bruno Hubert; Xavier de Lamballerie; Yazdan Yazdanpanah
Journal:  Clin Infect Dis       Date:  2016-07-28       Impact factor: 9.079

2.  Late sexual transmission of Zika virus related to persistence in the semen.

Authors:  Jean Marie Turmel; Pierre Abgueguen; Bruno Hubert; Yves Marie Vandamme; Marianne Maquart; Hélène Le Guillou-Guillemette; Isabelle Leparc-Goffart
Journal:  Lancet       Date:  2016-06-07       Impact factor: 79.321

3.  Probable sexual transmission of Zika virus from a vasectomised man.

Authors:  Marta Arsuaga; Silvia García Bujalance; Marta Díaz-Menéndez; Ana Vázquez; Jose R Arribas
Journal:  Lancet Infect Dis       Date:  2016-09-19       Impact factor: 25.071

4.  Zika virus in semen and spermatozoa.

Authors:  Jean Michel Mansuy; Elsa Suberbielle; Sabine Chapuy-Regaud; Catherine Mengelle; Louis Bujan; Bruno Marchou; Pierre Delobel; Daniel Gonzalez-Dunia; Cécile E Malnou; Jacques Izopet; Guillaume Martin-Blondel
Journal:  Lancet Infect Dis       Date:  2016-09-19       Impact factor: 25.071

Review 5.  Sexual transmission of Zika virus: a literature review.

Authors:  Miranda Sherley; Chong-Wei Ong
Journal:  Sex Health       Date:  2018-06       Impact factor: 2.706

6.  Effect of acute Zika virus infection on sperm and virus clearance in body fluids: a prospective observational study.

Authors:  Guillaume Joguet; Jean-Michel Mansuy; Giulia Matusali; Safouane Hamdi; Marie Walschaerts; Lynda Pavili; Stefanie Guyomard; Nadia Prisant; Pierre Lamarre; Nathalie Dejucq-Rainsford; Christophe Pasquier; Louis Bujan
Journal:  Lancet Infect Dis       Date:  2017-08-23       Impact factor: 25.071

7.  Zika Virus Infection in Pregnant Women in Rio de Janeiro.

Authors:  Patrícia Brasil; José P Pereira; M Elisabeth Moreira; Rita M Ribeiro Nogueira; Luana Damasceno; Mayumi Wakimoto; Renata S Rabello; Stephanie G Valderramos; Umme-Aiman Halai; Tania S Salles; Andrea A Zin; Dafne Horovitz; Pedro Daltro; Marcia Boechat; Claudia Raja Gabaglia; Patrícia Carvalho de Sequeira; José H Pilotto; Raquel Medialdea-Carrera; Denise Cotrim da Cunha; Liege M Abreu de Carvalho; Marcos Pone; André Machado Siqueira; Guilherme A Calvet; Ana E Rodrigues Baião; Elizabeth S Neves; Paulo R Nassar de Carvalho; Renata H Hasue; Peter B Marschik; Christa Einspieler; Carla Janzen; James D Cherry; Ana M Bispo de Filippis; Karin Nielsen-Saines
Journal:  N Engl J Med       Date:  2016-03-04       Impact factor: 91.245

8.  Potential for Zika virus transmission through blood transfusion demonstrated during an outbreak in French Polynesia, November 2013 to February 2014.

Authors:  D Musso; T Nhan; E Robin; C Roche; D Bierlaire; K Zisou; A Shan Yan; V M Cao-Lormeau; J Broult
Journal:  Euro Surveill       Date:  2014-04-10

9.  Zika virus causes testicular atrophy.

Authors:  Ryuta Uraki; Jesse Hwang; Kellie Ann Jurado; Sarah Householder; Laura J Yockey; Andrew K Hastings; Robert J Homer; Akiko Iwasaki; Erol Fikrig
Journal:  Sci Adv       Date:  2017-02-22       Impact factor: 14.136

10.  Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007.

Authors:  Robert S Lanciotti; Olga L Kosoy; Janeen J Laven; Jason O Velez; Amy J Lambert; Alison J Johnson; Stephanie M Stanfield; Mark R Duffy
Journal:  Emerg Infect Dis       Date:  2008-08       Impact factor: 6.883

View more
  9 in total

1.  Tale of Viruses in Male Infertility.

Authors:  Shreya Das; Arunima Mondal; Jayeeta Samanta; Santanu Chakraborty; Arunima Sengupta
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

2.  Zika virus persistence in the male macaque reproductive tract.

Authors:  Erin E Ball; Patricia A Pesavento; Koen K A Van Rompay; M Kevin Keel; Anil Singapuri; Jose P Gomez-Vazquez; Dawn M Dudley; David H O'Connor; Meghan E Breitbach; Nicholas J Maness; Blake Schouest; Antonito Panganiban; Lark L Coffey
Journal:  PLoS Negl Trop Dis       Date:  2022-07-05

Review 3.  Twenty-First Century Viral Pandemics: A Literature Review of Sexual Transmission and Fertility Implications in Men.

Authors:  Kelly Payne; Peter Kenny; Jason M Scovell; Kajal Khodamoradi; Ranjith Ramasamy
Journal:  Sex Med Rev       Date:  2020-07-24

4.  A Peptide-Based Virus Inactivator Protects Male Mice Against Zika Virus-Induced Damage of Testicular Tissue.

Authors:  Lulu Si; Yu Meng; Fang Tian; Weihua Li; Peng Zou; Qian Wang; Wei Xu; Yuzhu Wang; Minjie Xia; Jingying Hu; Shibo Jiang; Lu Lu
Journal:  Front Microbiol       Date:  2019-09-27       Impact factor: 5.640

5.  A Redox-Probe-Free Immunosensor Based on Electrocatalytic Prussian Blue Nanostructured Film One-Step-Prepared for Zika Virus Diagnosis.

Authors:  Lorenna K B Santos; Priscila D Mendonça; LiLian K S Assis; Carlos R Prudêncio; Maria Izabel F Guedes; Ernesto T A Marques; Rosa Fireman Dutra
Journal:  Biosensors (Basel)       Date:  2022-08-10

Review 6.  Evidence of Spreading Zika Virus Infection Caused by Males of Different Species.

Authors:  Thayane da Encarnação Sá-Guimarães; Monica Ferreira Moreira
Journal:  Viruses       Date:  2022-09-15       Impact factor: 5.818

7.  Experimental Infection of Mid-Gestation Pregnant Female and Intact Male Sheep with Zika Virus.

Authors:  Erika R Schwarz; Lilian J Oliveira; Francesco Bonfante; Ruiyu Pu; Malgorzata A Pozor; N James Maclachlan; Sarah Beachboard; Kelli L Barr; Maureen T Long
Journal:  Viruses       Date:  2020-03-07       Impact factor: 5.048

8.  Montelukast, an Anti-asthmatic Drug, Inhibits Zika Virus Infection by Disrupting Viral Integrity.

Authors:  Yongkang Chen; Yuan Li; Xiaohuan Wang; Peng Zou
Journal:  Front Microbiol       Date:  2020-01-30       Impact factor: 5.640

Review 9.  Maternal-Fetal Interplay in Zika Virus Infection and Adverse Perinatal Outcomes.

Authors:  Franciane Mouradian Emidio Teixeira; Anna Julia Pietrobon; Luana de Mendonça Oliveira; Luanda Mara da Silva Oliveira; Maria Notomi Sato
Journal:  Front Immunol       Date:  2020-02-14       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.